Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Sotalol Market Size Growth Rate by Type
1.3.2 40mg
1.3.3 80mg
1.4 Market Segment by Application
1.4.1 Global Sotalol Market Share by Application (2018-2025)
1.4.2 Sustained Ventricular Tachycardia
1.4.3 Atrial Fibrillation/Flutter
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sotalol Market Size
2.1.1 Global Sotalol Revenue 2013-2025
2.1.2 Global Sotalol Sales 2013-2025
2.2 Sotalol Growth Rate by Regions
2.2.1 Global Sotalol Sales by Regions 2013-2018
2.2.2 Global Sotalol Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Sotalol Sales by Manufacturers
3.1.1 Sotalol Sales by Manufacturers 2013-2018
3.1.2 Sotalol Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 Sotalol Revenue by Manufacturers (2013-2018)
3.2.2 Sotalol Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Sotalol Market Concentration Ratio (CR5 and HHI)
3.3 Sotalol Price by Manufacturers
3.4 Key Manufacturers Sotalol Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Sotalol Market
3.6 Key Manufacturers Sotalol Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 40mg Sales and Revenue (2013-2018)
4.1.2 80mg Sales and Revenue (2013-2018)
4.2 Global Sotalol Sales Market Share by Type
4.3 Global Sotalol Revenue Market Share by Type
4.4 Sotalol Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Sotalol Sales by Application
6 North America
6.1 North America Sotalol Breakdown Data by Company
6.2 North America Sotalol Breakdown Data by Type
6.3 North America Sotalol Breakdown Data by Application
6.4 North America Sotalol Breakdown Data by Countries
6.4.1 North America Sotalol Sales by Countries
6.4.2 North America Sotalol Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
7 Europe
7.1 Europe Sotalol Breakdown Data by Company
7.2 Europe Sotalol Breakdown Data by Type
7.3 Europe Sotalol Breakdown Data by Application
7.4 Europe Sotalol Breakdown Data by Countries
7.4.1 Europe Sotalol Sales by Countries
7.4.2 Europe Sotalol Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Sotalol Breakdown Data by Company
8.2 Asia Pacific Sotalol Breakdown Data by Type
8.3 Asia Pacific Sotalol Breakdown Data by Application
8.4 Asia Pacific Sotalol Breakdown Data by Countries
8.4.1 Asia Pacific Sotalol Sales by Countries
8.4.2 Asia Pacific Sotalol Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam
9 Central & South America
9.1 Central & South America Sotalol Breakdown Data by Company
9.2 Central & South America Sotalol Breakdown Data by Type
9.3 Central & South America Sotalol Breakdown Data by Application
9.4 Central & South America Sotalol Breakdown Data by Countries
9.4.1 Central & South America Sotalol Sales by Countries
9.4.2 Central & South America Sotalol Revenue by Countries
9.4.3 Brazil
10 Middle East and Africa
10.1 Middle East and Africa Sotalol Breakdown Data by Type
10.2 Middle East and Africa Sotalol Breakdown Data by Application
10.3 Middle East and Africa Sotalol Breakdown Data by Countries
10.3.1 Middle East and Africa Sotalol Sales by Countries
10.3.2 Middle East and Africa Sotalol Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Sotalol
11.1.4 Sotalol Product Introduction
11.1.5 Bayer Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Sotalol
11.2.4 Sotalol Product Introduction
11.2.5 GSK Recent Development
11.3 Bristol-Myers Squibb (BMS)
11.3.1 Bristol-Myers Squibb (BMS) Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Sotalol
11.3.4 Sotalol Product Introduction
11.3.5 Bristol-Myers Squibb (BMS) Recent Development
11.4 Arbor Pharmaceuticals
11.4.1 Arbor Pharmaceuticals Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Sotalol
11.4.4 Sotalol Product Introduction
11.4.5 Arbor Pharmaceuticals Recent Development
11.5 Cambrex
11.5.1 Cambrex Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Sotalol
11.5.4 Sotalol Product Introduction
11.5.5 Cambrex Recent Development
11.6 Arevipharma
11.6.1 Arevipharma Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Sotalol
11.6.4 Sotalol Product Introduction
11.6.5 Arevipharma Recent Development
11.7 Shaanxi Hanjiang Pharmaceutical Group
11.7.1 Shaanxi Hanjiang Pharmaceutical Group Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Sotalol
11.7.4 Sotalol Product Introduction
11.7.5 Shaanxi Hanjiang Pharmaceutical Group Recent Development
11.8 Samarth Pharma Pvt. Ltd.
11.8.1 Samarth Pharma Pvt. Ltd. Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Sotalol
11.8.4 Sotalol Product Introduction
11.8.5 Samarth Pharma Pvt. Ltd. Recent Development
11.9 Cipla Limited
11.9.1 Cipla Limited Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Sotalol
11.9.4 Sotalol Product Introduction
11.9.5 Cipla Limited Recent Development
12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Sotalol Sales Channels
12.2.2 Sotalol Distributors
12.3 Sotalol Customers
13 Market Forecast
13.1 Global Sotalol Sales and Revenue Forecast 2018-2025
13.2 Global Sotalol Sales Forecast by Type
13.3 Global Sotalol Sales Forecast by Application
13.4 Sotalol Forecast by Regions
13.4.1 Global Sotalol Sales Forecast by Regions 2018-2025
13.4.2 Global Sotalol Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America Sotalol Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Sotalol Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Sotalol Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Sotalol Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Sotalol Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
【掲載企業】
Bayer、GSK、Bristol-Myers Squibb (BMS)、Arbor Pharmaceuticals、Cambrex、Arevipharma、Shaanxi Hanjiang Pharmaceutical Group、Samarth Pharma Pvt. Ltd.、Cipla Limited
【免責事項】
https://www.globalresearch.jp/disclaimer